Biogen Pharmachem Industries Ltd Q3 FY2023-2024 Results: Summary
Revenue | ₹0.09Cr |
Net Profits | ₹0.06Cr |
Net Profit Margins | 66.67% |
Highlights
Revenue:
Biogen Pharmachem Industries Ltd’s revenue fell -72.73% since last year same period to ₹0.09Cr in the Q3 2023-2024. On a quarterly growth basis, Biogen Pharmachem Industries Ltd has generated -88.16% fall in its revenue since last 3-months.
Net Profits:
Biogen Pharmachem Industries Ltd’s net profit fell -80% since last year same period to ₹0.06Cr in the Q3 2023-2024. On a quarterly growth basis, Biogen Pharmachem Industries Ltd has generated -91.67% fall in its net profits since last 3-months.
Net Profit Margins:
Biogen Pharmachem Industries Ltd’s net profit margin fell -26.67% since last year same period to 66.67% in the Q3 2023-2024. On a quarterly growth basis, Biogen Pharmachem Industries Ltd has generated -29.63% fall in its net profit margins since last 3-months.
